CBD triggered the production of immune-suppressive cells in mice through mast cells and a fat-sensing receptor

CBD administration in mice activated mast cells and the PPAR-gamma receptor, leading to mobilization of myeloid-derived suppressor cells that potently suppressed T cell activity and reduced acute inflammation.

Hegde, Venkatesh L et al.·Journal of immunology (Baltimore·2015·Preliminary EvidenceAnimal StudyAnimal Study
RTHC-00977Animal StudyPreliminary Evidence2015RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Researchers discovered that CBD administration in mice triggered a robust immune response: the mobilization of myeloid-derived suppressor cells (MDSCs) in the abdominal cavity. These MDSCs expressed functional arginase 1 and potently suppressed T cell proliferation.

The mechanism involved mast cells and the PPAR-gamma receptor (peroxisome proliferator-activated receptor gamma). CBD was shown to enhance PPAR-gamma transcriptional activity, and blocking this receptor completely prevented MDSC induction. Mast cell-deficient mice showed markedly reduced MDSC responses.

CBD-induced MDSCs were functional: when transferred to other mice, they suppressed LPS-induced acute inflammatory responses. The findings reveal a previously unknown pathway through which CBD modulates the immune system.

Key Numbers

CBD induced CD11b+Gr-1+ MDSCs in peritoneum. Both granulocytic and monocytic MDSC subtypes induced. Monocytic MDSCs showed higher suppressive function. MDSC induction markedly reduced in mast cell-deficient mice. PPAR-gamma antagonist completely blocked MDSC induction.

How They Did This

Controlled animal study using wild-type and mast cell-deficient (Kit-mutant) mice. CBD was administered and MDSC induction was measured by flow cytometry. Functional suppression was tested via T cell proliferation assays and adoptive transfer experiments. PPAR-gamma involvement was confirmed using reporter assays and selective antagonists.

Why This Research Matters

Understanding the specific immune pathways through which CBD works is essential for developing CBD-based therapies. This study identified a concrete molecular pathway (PPAR-gamma in mast cells leading to G-CSF and MDSC mobilization) that could be targeted more precisely.

The Bigger Picture

CBD's immune-modulating effects have been broadly observed but poorly understood mechanistically. This study provides one of the clearest mechanistic pathways yet, connecting CBD to immune suppression through mast cells, PPAR-gamma, and MDSC mobilization. However, immune suppression is a double-edged sword.

What This Study Doesn't Tell Us

Animal study using naive (healthy) mice. The immune-suppressive effects in healthy animals may not directly translate to therapeutic contexts. Long-term consequences of MDSC mobilization are unknown and could include impaired anti-tumor immunity. Doses may not translate to human use.

Questions This Raises

  • ?Could chronic CBD use suppress beneficial immune surveillance?
  • ?Does this pathway operate in humans?
  • ?Could the MDSC-mobilizing effect of CBD be harmful in cancer patients?
  • ?Is this mechanism relevant to CBD's reported anti-inflammatory clinical effects?

Trust & Context

Key Stat:
PPAR-gamma antagonist completely blocked CBD's immune-suppressive effect
Evidence Grade:
Detailed mechanistic animal study identifying a specific molecular pathway. No human data for this mechanism.
Study Age:
Published in 2015. CBD immunology research has continued with additional mechanistic studies.
Original Title:
Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.
Published In:
Journal of immunology (Baltimore, Md. : 1950), 194(11), 5211-22 (2015)
Database ID:
RTHC-00977

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

How does CBD affect the immune system?

This study found CBD activates a receptor called PPAR-gamma in mast cells, which triggers the release of a growth factor (G-CSF) that mobilizes immune-suppressive cells (MDSCs). These cells potently suppress T cell activity and reduce inflammation.

Could CBD suppress the immune system too much?

This is a legitimate concern raised by this study. While immune suppression can reduce inflammation, it could also impair the body's ability to fight infections or tumors. The clinical significance in humans is not yet known.

Read More on RethinkTHC

Cite This Study

RTHC-00977·https://rethinkthc.com/research/RTHC-00977

APA

Hegde, Venkatesh L; Singh, Udai P; Nagarkatti, Prakash S; Nagarkatti, Mitzi. (2015). Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.. Journal of immunology (Baltimore, Md. : 1950), 194(11), 5211-22. https://doi.org/10.4049/jimmunol.1401844

MLA

Hegde, Venkatesh L, et al. "Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.." Journal of immunology (Baltimore, 2015. https://doi.org/10.4049/jimmunol.1401844

RethinkTHC

RethinkTHC Research Database. "Critical Role of Mast Cells and Peroxisome Proliferator-Acti..." RTHC-00977. Retrieved from https://rethinkthc.com/research/hegde-2015-critical-role-of-mast

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.